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QT DYNAMICITY PREDICTS SHORT TERM MORTALITY 
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Introduction — Sympathetic overactivity increases the risk of 
ventricular arrhythmias. Previous studies showed that alteration 
of QT dynamicity, re ecting abnormal sympathetic modulation of 
ventricular repolarisation, is independently predictive of sudden 
cardiac death among patients with chronic heart failure. The aim 
of this study was to determine whether impaired adaptation of 
the QT interval to changes in heart rate also predicts death at one 
month in patients with acute heart failure.
Methods — In this study, we prospectively included 99 patients (mean 
age 71+/-13 years) with acute heart failure (EF = 35,2±13,4 %, BNP 
= 1045±83 pg/ml). Heart rate variability and QT dynamicity was 
evaluated by analyzing 24-h Holter recordings. The linear regression 
slope of QT interval measured to the apex and to the end of T wave 
plotted against RR intervals was calculated using dedicated Holter 
algorithm. Clinical, biological and morphological data were collected. 
Follow-up was performed by direct examination or.
Results — After a follow up of one month 21 patients died. 
Non survivors were older (76+/8 vs. 69±15 years, p<0,05), 
had signi cantly decreased ejection fraction (28,8±12,7 % vs. 
36,9±13,1 %, p<0,05), lower hemoglobin levels (11,4±1,7 g/dl vs. 
12,5±2,3 g/dl, p<0,05) and red blood cells (3650±458 1000/l vs. 
4287±771 1000/l, p<0,05). Among parameters issued from 24-h 
Holter-EKG analysis only day QTe slope was signi cantly decreased 
in non survivors (0,33±0,23 vs 0,56±0,64, p<0,05).
Conclusion — These results suggest that clinical, biological and 
electrical parameters issued from 24 hours Holter-ECG recording 
are able to predict short term mortality in patients with acute heart 
failure. These preliminary results need to be con rmed by a more 
extensive statistical approach currently ongoing. These predictive 
parameters are simple to use and their clinical or pharmacological 
interest need to be con rmed.
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Frequency-domain analysis of heart rate variation has been 
suggested as an effective screening tool for sleep apnoea syndrome 
(SAS) in the general population. The aim of this study was to 
determine whether this method could be effective in patients with 
chronic congestive heart failure (CHF). 84 patients with stable CHF, 
left ventricular ejection fraction (LVEF) <45 %, and sinus rhythm 
were included prospectively. Patients underwent simultaneous 
polygraphy to measure apnoea/hypopnoea index (AHI) and ECG 
Holter monitoring to measure the power spectral density of the very 
low frequency component of the heart rate increment, expressed 
as the percentage of total power spectral density (% VLFI).
VLFI could be determined in 54 patients (mean age 52.8+/-12.3 
years and LVEF 33.5+/-9.8 %). SAS de ned as AHI >=15•h-1 was 
diagnosed in 57.4 % of patients. % VLFI was not correlated with AHI (R 
= 0.12). Receiver operating characteristic curves constructed using 
various AHI cut-offs (5 to 30.h-1) failed to identify a % VLFI cut-off 
associated with SAS. The 2.4 % VLFI cut-off recommended for the 
general population of patients with suspected SAS had low values 
for speci city (35 %), positive and negative predictive value (35 % 
and 54 % respectively). Heart rate increment analysis demonstrated 
several limitations in CHF. At this time, HRV methodology could not 
be proposed as the  rst step of SAS screening in CHF population.
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Pulmonary Hypertension (PAH) is frequent in patient with advanced 
Heart Failure (HF). One of the underlying mechanisms of this 
pathogenic pathway could be a reduced ability of the arteriolar 
vascular smooth muscle to relax. The cGMP plays an important 
in the regulation of pulmonary vascular tone and its clearance is 
dependant of phosphodiesterase 5 (PDE 5). The aim of this study 
was to investigate whether or not the PDE 5 G(-1142)T genotype 
was associated with PAH and could affect the NO-inhaled response 
in HF.
Methods — HF patients underwent VO2, echocardiography 24h 
before the right side cardiac catheterization. Hemodynamic 
parameters, cGMP plasma level (n=12) were made after Air and 
20ppm NO gas breathing. The PCR-restriction fragment length 
polymorphism method was used to determine the PDE5 G/T gene.
Subjects: We included 72 HF patients. Most of the patients had a 
ischemic cardiomyopathy (54 %). The mean LVEF was 29±1 and age 
was 53±1. The mean pulmonary artery pressure was 25.5±1.3mmHg. 
The genotype TT, GT, GG and G(-1142) allele frequency distribution 
was respectively 38.9 %, 41.7 %, 19.4 % and 40.3 %.
Results — Baseline characteristics were similar between the three 
genotypes except for the cGMP which was signi cantly decrease 
in TT genotype versus GG-GT group (p=0.02) Furthermore the 
pulmonary capillary wedge pressure (PCWP) trend to decrease in 
TT genotype (p=0.09). These results suggested that PDE 5 activity 
is increase in patient with TT genotype and may increase the 
pulmonary artery tone. NO-inhaled PVR was signi cantly different 
between the three subgroups (Anova for repeated measures: 
p=0.002) and was more important in the TT group with a decrease 
of PVR of 33 % versus 1.6 % in GG and 0 % in GT subgroups. The 
PVR decrease is explained by a superior increase in PCWP in TT 
genotype after NO inhalation. Our hypothesis is that the greatest 
NO-inhaled response in TT genotype is due to a greater degree of 
pulmonary vasoconstriction tone at baseline.
Conclusion — We  rst demonstrate that G(-1142) polymorphism of 
PDE 5 is functional and may regulate the basal pulmonary artery 
tone at baseline and increase the NO-inhaled response in Heart 
Failure.
